article · La Tunisie Médicale
The Middle East, Mediterranean, and Africa (MEMA) region, encompassing 68 countries and 20% of the global population, contributes only 6% of the world's registered clinical trials. This editorial identifies eight key barriers to clinical research in the region: (1) limited collaboration with high-income country (HIC) universities supporting low-income country (LIC) research, (2) insufficient specialized training programs, (3) inadequate laboratory and technological infrastructure, (4) lack of research methodology integration in medical curricula, (5) underdeveloped local institutional review boards, (6) insufficient and unsustainable funding, (7) limited technology transfer from HICs to LICs, and (8) migration of skilled professionals to HICs. These challenges hinder the region's research capacity and global contribution. Proposed solutions include fostering HIC-LMIC partnerships, enhancing training through scholarships and local research centers, improving infrastructure via international collaboration, and developing robust ethical review systems. By addressing these barriers, LMICs can increase their contribution to global clinical research, promoting equitable health outcomes.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.62438/tunismed.v103i9.6490
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.